Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P Dorado
Use of Pharmacogenetics in Bioequivalence Studies to Reduce Sample Size: An Example With Mirtazapine and CYP2D6
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short-Acting Β-Agonist Formulations
Journal of Clinical Pharmacology
Pharmacology
Adaptive Two-Stage Bioequivalence Trials With Early Stopping and Sample Size Re-Estimation
Trials
Medicine
Pharmacology
Impact of CYP2D6*10 Polymorphism on the Pharmacokinetics of Mirtazapine and Its Desmethylated Metabolite in Japanese Psychiatric Patients Treated With Mirtazapine
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
MDMA, Methamphetamine, and CYP2D6 Pharmacogenetics: What Is Clinically Relevant?
Frontiers in Genetics
Genetics
Molecular Medicine
Use of Mirtazapine in Children and Adolescents
Progress in Neurology and Psychiatry
Psychiatry
Mental Health
Neurology
Psychiatric Mental Health
Simple Nomograms to Calculate Sample Size in Diagnostic Studies
Emergency Medicine Journal
Medicine
Critical Care
Emergency Medicine
Intensive Care Medicine
Sample Size in Pilot Genetic Studies
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
The Role of CYP2D6 and ABCB1 Pharmacogenetics in Drug-Naïve Patients With First-Episode Schizophrenia Treated With Risperidone
European Journal of Clinical Pharmacology
Medicine
Pharmacology
An Updated Survey on Statistical Thresholding and Sample Size of fMRI Studies
Frontiers in Human Neuroscience
Mental Health
Neuropsychology
Physiological Psychology
Neurology
Behavioral Neuroscience
Psychiatry
Biological Psychiatry